BillionToOne (BLLN) Total Non-Current Liabilities (2024 - 2025)
BillionToOne (BLLN) posted Total Non-Current Liabilities of $152.5 million for Q4 2025, up 6.47% sequentially from $143.3 million in Q3 2025, and up 15.97% YoY from $131.5 million in Q4 2024.
BillionToOne (BLLN) Total Non-Current Liabilities (2024 - 2025) Analysis & Trends
BillionToOne has reported Total Non-Current Liabilities for 2 years, with the latest figure at $152.5 million in Q4 2025.
- Quarterly Total Non-Current Liabilities rose 15.97% year-over-year to $152.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $152.5 million (up 15.97% YoY) and the FY2025 annual result came in at $152.5 million, up 15.97% from the prior year.
- Total Non-Current Liabilities rose to $152.5 million in Q4 2025 per BLLN's latest filing, from $143.3 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $152.5 million in Q4 2025 and troughed at $131.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 715.49 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 542.10 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.19 Bn |
| 10 | BillionToOne | 4.42 Bn | 3.87 Bn | 77.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 152.55 Mn |
| Sep 30, 2025 | 143.28 Mn |
| Dec 31, 2024 | 131.54 Mn |